Research map: The role of lipoprotein (a) in premature cardiovascular disease: primed for prevention

Back to the article

Papers in this map

  1. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 · Gregory A. Roth · 2018 · 8781 citations · Cited by this paper
  2. Interplay of HDL cholesterol and apoB and the risk of incident atherosclerotic cardiovascular disease in UK Biobank · 2026 · Related
  3. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement · Florian Kronenberg · 2022 · 1455 citations · Cited by this paper
  4. Rheumatoid arthritis and risk of myocardial infarction: A nationwide cohort study · 2026 · Related
  5. Development and Validation of the American Heart Association’s PREVENT Equations · Sadiya S. Khan · 2023 · 1163 citations · Cited by this paper
  6. Beyond Survival: The Eriksen Case and the Dilemma of Elite Sport Participation After Sudden Cardiac Arrest · 2026 · Related
  7. Lipoprotein(a) Reduction in Persons with Cardiovascular Disease · Sotirios Tsimikas · 2020 · 1081 citations · Cited by this paper
  8. Cardiovascular prevention in childhood and young adults · 2026 · Related
  9. Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association · Gissette Reyes-Soffer · 2021 · 778 citations · Cited by this paper
  10. Rethinking how we characterize the exercise blood pressure response in athletes · 2026 · Related
  11. Lp(a) (Lipoprotein[a]) Concentrations and Incident Atherosclerotic Cardiovascular Disease · Aniruddh P. Patel · 2020 · 558 citations · Cited by this paper
  12. Navigating Clinical Likelihood and Cardiovascular Risk over a Lifetime Course of Coronary Artery Disease · 2026 · Related
  13. NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis · Sotirios Tsimikas · 2018 · 509 citations · Cited by this paper
  14. Baseline Anemia and Short Dual Antiplatelet Therapy in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention · 2026 · Related
  15. Impact of Thrombophilia on Risk of Arterial Ischemic Stroke or Cerebral Sinovenous Thrombosis in Neonates and Children · Gili Kenet · 2010 · 447 citations · Cited by this paper
  16. Safe hearts need a healthy environment: prevention beyond our clinic walls · 2026 · Related
  17. Associations of Coronary Heart Disease Risk Factors With the Intermediate Lesion of Atherosclerosis in Youth · Henry C. McGill · 2000 · 421 citations · Cited by this paper
  18. Multidisciplinary cardiac rehabilitation—an indispensable therapeutic intervention when starting a GLP-1 receptor agonist therapy? · 2026 · Related
  19. Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis · Romain Capoulade · 2015 · 414 citations · Cited by this paper
  20. Pharmacological risk stratification of Lp(a): diabetes status may refine residual cardiovascular risk beyond ASCVD history · 2026 · Related
  21. A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice · Marlys L. Koschinsky · 2024 · 324 citations · Cited by this paper
  22. HEART UK consensus statement on Lipoprotein(a): A call to action · Jaimini Cegla · 2019 · 247 citations · Cited by this paper
  23. Lipoprotein(a) Is Markedly More Atherogenic Than LDL · Elias Björnson · 2024 · 236 citations · Cited by this paper
  24. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia · Roger Scott Blumenthal · 2026 · 232 citations · Cited by this paper
  25. Non-genetic influences on lipoprotein(a) concentrations · Byambaa Enkhmaa · 2022 · 194 citations · Cited by this paper
  26. Current Management of Calcific Aortic Stenosis · Brian R. Lindman · 2013 · 172 citations · Cited by this paper
  27. Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society · Florian Kronenberg · 2023 · 154 citations · Cited by this paper
  28. Ancestry, Lipoprotein(a), and Cardiovascular Risk Thresholds · Sotirios Tsimikas · 2022 · 150 citations · Cited by this paper
  29. Lipoprotein(a) levels in a global population with established atherosclerotic cardiovascular disease · Steven E. Nissen · 2022 · 141 citations · Cited by this paper
  30. Lipoprotein(a) Testing Trends in a Large Academic Health System in the United States · Harpreet Singh Bhatia · 2023 · 126 citations · Cited by this paper
  31. Lipoprotein(a): An independent, genetic, and causal factor for cardiovascular disease and acute myocardial infarction · Enas A. Enas · 2019 · 121 citations · Cited by this paper
  32. Ideal cardiovascular health influences cardiovascular disease risk associated with high lipoprotein(a) levels and genotype: The EPIC-Norfolk prospective population study · Nicolas Perrot · 2016 · 119 citations · Cited by this paper
  33. Lp(a) Lipoprotein Is an Independent, Discriminating Risk Factor for Premature Peripheral Atherosclerosis Among White Men · R. James Valentine · 1994 · 117 citations · Cited by this paper
  34. Atherogenecity of lipoprotein(a) and oxidized low density lipoprotein: insight from in vivo studies of arterial wall influx, degradation and efflux · Lars B. Nielsen · 1999 · 116 citations · Cited by this paper
  35. Therapeutic Inertia in Cardiovascular Disease Prevention · Dave L. Dixon · 2019 · 106 citations · Cited by this paper
  36. Lipoprotein(a) and Long-Term Cardiovascular Risk in a Multi-Ethnic Pooled Prospective Cohort · Nathan D. Wong · 2024 · 105 citations · Cited by this paper
  37. Lipoprotein(a) and Risks of Peripheral Artery Disease, Abdominal Aortic Aneurysm, and Major Adverse Limb Events · Peter Engel Thomas · 2023 · 100 citations · Cited by this paper
  38. Lipoprotein(a) levels from childhood to adulthood: Data in nearly 3,000 children who visited a pediatric lipid clinic · Lotte M. de Boer · 2022 · 97 citations · Cited by this paper
  39. Lipoprotein(a) is associated with large artery atherosclerosis stroke aetiology and stroke recurrence among patients below the age of 60 years: results from the BIOSIGNAL study · Markus Arnold · 2021 · 96 citations · Cited by this paper

Source: OpenAlex (CC0)